Gynecologic Cancer News

The addition of cadonilimab to first-line chemotherapy improved outcomes among certain women with cervical cancer.

Higher omega-3 and omega-6 fatty acid levels may help reduce cancer risk, according to study findings.

Lack of health insurance contributes to a high percentage of racial and ethnic disparities in advanced-stage diagnoses for several cancer types, according to results of a mediation analysis.

In this video, Elizabeth Lee, MD, of the Dana-Farber Cancer Institute, highlighted promising endometrial cancer presentations from ESMO Congress.

CHICAGO — Patients treated with mirvetuximab require close follow-up with an ophthalmologist due to the potential for corneal toxicity, according to a study.

The use of chatbot tools may be a valuable part of health management strategies to improve access to cancer genetic services, according to study results.

Stage at diagnosis and survival among younger individuals with cancer varied considerably by race, according to a retrospective cohort study.

A novel drug delivery construct may protect individuals against cisplatin-induced ototoxicity and associated hearing loss.

People with MS had an increased risk for bladder, brain and cervical cancers compared with people without MS, according to a new study in Neurology, the medical journal of the American Academy of Neurology.